A detailed history of Martin & CO Inc transactions in Pfizer Inc stock. As of the latest transaction made, Martin & CO Inc holds 42,979 shares of PFE stock, worth $1.2 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
42,979
Previous 44,121 2.59%
Holding current value
$1.2 Million
Previous $1.27 Million 6.14%
% of portfolio
0.31%
Previous 0.33%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $29,566 - $33,951
-1,142 Reduced 2.59%
42,979 $1.19 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $57,982 - $75,312
-2,219 Reduced 4.79%
44,121 $1.27 Million
Q3 2023

Nov 02, 2023

BUY
$32.09 - $37.51 $39,438 - $46,099
1,229 Added 2.72%
46,340 $1.54 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $77,152 - $89,263
-2,136 Reduced 4.52%
45,111 $1.65 Million
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $31,393 - $40,870
-797 Reduced 1.66%
47,247 $1.93 Million
Q4 2022

Feb 03, 2023

BUY
$41.75 - $54.5 $49,557 - $64,691
1,187 Added 2.53%
48,044 $2.46 Million
Q3 2022

Oct 26, 2022

BUY
$43.76 - $53.42 $48,792 - $59,563
1,115 Added 2.44%
46,857 $2.05 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $18,798 - $22,288
404 Added 0.89%
45,742 $2.4 Million
Q1 2022

May 04, 2022

SELL
$45.75 - $56.69 $150,517 - $186,510
-3,290 Reduced 6.77%
45,338 $2.35 Million
Q4 2021

Feb 01, 2022

SELL
$41.32 - $61.25 $9,420 - $13,965
-228 Reduced 0.47%
48,628 $2.87 Million
Q3 2021

Nov 02, 2021

BUY
$39.25 - $50.42 $149,150 - $191,596
3,800 Added 8.43%
48,856 $2.1 Million
Q2 2021

Jul 28, 2021

SELL
$35.91 - $40.68 $68,121 - $77,169
-1,897 Reduced 4.04%
45,056 $1.76 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $25,854 - $29,158
-772 Reduced 1.62%
46,953 $1.7 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $2,677 - $3,404
80 Added 0.17%
47,725 $1.76 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $24,765 - $29,055
-780 Reduced 1.61%
47,645 $1.75 Million
Q2 2020

Aug 19, 2020

BUY
$30.12 - $36.54 $40,270 - $48,853
1,337 Added 2.84%
48,425 $1.58 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $27,408 - $39,160
1,014 Added 2.2%
47,088 $1.54 Million
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $1,646 - $1,868
50 Added 0.11%
46,074 $1.81 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $17,219 - $22,328
-530 Reduced 1.14%
46,024 $1.65 Million
Q2 2019

Aug 15, 2019

SELL
$36.98 - $41.52 $32,727 - $36,745
-885 Reduced 1.87%
46,554 $2.02 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $35,925 - $39,469
958 Added 2.06%
47,439 $2.02 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $10,579 - $12,061
-275 Reduced 0.59%
46,481 $2.03 Million
Q3 2018

Nov 15, 2018

SELL
$34.47 - $41.81 $19,647 - $23,831
-570 Reduced 1.2%
46,756 $2.06 Million
Q2 2018

Aug 15, 2018

SELL
$32.98 - $35.16 $12,862 - $13,712
-390 Reduced 0.82%
47,326 $1.72 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $25,017 - $29,023
-784 Reduced 1.62%
47,716 $1.69 Million
Q4 2017

Feb 15, 2018

BUY
$33.26 - $35.29 $10,310 - $10,939
310 Added 0.64%
48,500 $1.76 Million
Q3 2017

Nov 15, 2017

SELL
$31.0 - $34.15 $112,375 - $123,793
-3,625 Reduced 7.0%
48,190 $1.72 Million
Q2 2017

Aug 15, 2017

BUY
N/A
51,815
51,815 $1.74 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Martin & CO Inc Portfolio

Follow Martin & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Martin & CO Inc with notifications on news.